The journey of rapamycin from a soil-derived antifungal compound discovered on Easter Island to one of the most studied longevity interventions represents a remarkable evolution in pharmaceutical science. Initially developed as an immunosuppressant for organ transplantation, rapamycin has emerged as the leading candidate for pharmacological intervention in aging, supported by unprecedented consi..